Senior Program Director - Resarch Site Director
Oncodesign-services, France
Nicolas Ancellin, PhD, head of Oncodesign-services research center. Nicolas Ancellin is an experienced cell and molecular biologist specializing in drug discovery. He completed his post-doctoral fellowship at UCONN researching angiogenesis signaling before joining GlaxoSmithKline in 2002, where he successfully led multiple drug discovery projects and gained expertise in target identification and validation. Since joining Oncodesign in 2016, he has been instrumental in developing a LRRK2 kinase inhibitor (owned by Servier), which is currently in Phase I clinical trials. In his current role as the research site director and strategic project director at Oncodesign-services, Nicolas is actively involved in integrated drug discovery projects.